Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Feb 8 2022

Full Issue

Different Takes: What's The Data On Covid Shots For Kids Under 5?; Steps To End Omicron

Opinion writers weigh in on these covid topics.

Bloomberg: Can The FDA Get It Right On Covid Vaccines For Young Kids? 

An advisory committee will meet next week to discuss whether the Food and Drug Administration should authorize Pfizer’s Covid-19 vaccine for children younger than 5. To be more specific, they will meet to discuss data — data that no one but Pfizer and the FDA has yet seen — on the first two doses of what will probably be a three-shot series for those kids. (Lisa Jarvis, 2/7)

The Washington Post: What The Omicron Covid Wave Taught Us 

Thankfully, the omicron wave is easing, and much of the United States is now on the downward slope. This was the fifth wave of the pandemic, and if we have learned anything, it is that relaxing restrictions should be calibrated to local conditions. Tempers are frayed, face masks annoying and patience short, but the trick of downhill is to avoid reckless abandon. While deaths are terribly high, omicron infections are tumbling. New daily cases in the United States are the lowest since Dec. 12, and the seven-day average, while still high at about 300,000, has dropped 23 days in a row. Covid hospitalizations are falling, too. These indicators do not mean the pandemic is over, but it is headed in the right direction. (2/7)

Newsweek: When It Comes To Masks, The CDC Is Its Own Worst Enemy

Critics, pundits and social media accounts jump to accuse Joe Rogan of spreading COVID misinformation when he interviews experts who utter even a syllable with which they disagree. Yet they seem reluctant to call out the Centers for Disease Control and Prevention (CDC) for doing much worse. The CDC spread what amounts to misinformation in its promotion of cloth masks, which countless medical experts have said are useless against Omicron, the dominant COVID-19 variant in the United States. (Jason Rantz, 2/8)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF